BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 30060954)

  • 1. LncRNA LINC00641 predicts prognosis and inhibits bladder cancer progression through miR-197-3p/KLF10/PTEN/PI3K/AKT cascade.
    Li Z; Hong S; Liu Z
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1825-1829. PubMed ID: 30060954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA OIP5-AS1 loss-induced microRNA-410 accumulation regulates cell proliferation and apoptosis by targeting KLF10 via activating PTEN/PI3K/AKT pathway in multiple myeloma.
    Yang N; Chen J; Zhang H; Wang X; Yao H; Peng Y; Zhang W
    Cell Death Dis; 2017 Aug; 8(8):e2975. PubMed ID: 28796257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA GAS5 Suppresses the Proliferation and Invasion of Osteosarcoma Cells via the miR-23a-3p/PTEN/PI3K/AKT Pathway.
    Liu J; Chen M; Ma L; Dang X; Du G
    Cell Transplant; 2020; 29():963689720953093. PubMed ID: 33121268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulated lncRNA SLC25A5-AS1 facilitates cell growth and inhibits apoptosis via miR-19a-3p/PTEN/PI3K/AKT signalling pathway in gastric cancer.
    Li X; Yan X; Wang F; Yang Q; Luo X; Kong J; Ju S
    J Cell Mol Med; 2019 Apr; 23(4):2920-2932. PubMed ID: 30793479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive feedback between lncRNA FLVCR1-AS1 and KLF10 may inhibit pancreatic cancer progression via the PTEN/AKT pathway.
    Lin J; Zhai S; Zou S; Xu Z; Zhang J; Jiang L; Deng X; Chen H; Peng C; Zhang J; Shen B
    J Exp Clin Cancer Res; 2021 Oct; 40(1):316. PubMed ID: 34635142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA RP11-79H23.3 Functions as a Competing Endogenous RNA to Regulate PTEN Expression through Sponging hsa-miR-107 in the Development of Bladder Cancer.
    Chi H; Yang R; Zheng X; Zhang L; Jiang R; Chen J
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LINC00673 exerts oncogenic function in cervical cancer by negatively regulating miR-126-5p expression and activates PTEN/PI3K/AKT signaling pathway.
    Shi WJ; Liu H; Ge YF; Wu D; Tan YJ; Shen YC; Wang H; Xu H
    Cytokine; 2020 Dec; 136():155286. PubMed ID: 32950808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA BX357664 inhibits gastric cancer progression by sponging miR-183a-3p to regulate the PTEN expression and PI3K/AKT pathway.
    Liang LC; Liu LQ; Liu L; Liu DL; He YR; Wan X; Zhu ZQ; Zhang BG; Liu SJ; Wu H; Hu L
    Food Chem Toxicol; 2021 Apr; 150():112069. PubMed ID: 33607219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LINC00641 regulates autophagy and intervertebral disc degeneration by acting as a competitive endogenous RNA of miR-153-3p under nutrition deprivation stress.
    Wang XB; Wang H; Long HQ; Li DY; Zheng X
    J Cell Physiol; 2019 May; 234(5):7115-7127. PubMed ID: 30378116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN.
    Ramírez-Moya J; Wert-Lamas L; Santisteban P
    Oncogene; 2018 Jun; 37(25):3369-3383. PubMed ID: 29353884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. lncRNA MEG3 Suppresses the Tumorigenesis of Hemangioma by Sponging miR-494 and Regulating PTEN/ PI3K/AKT Pathway.
    Dai Y; Wan Y; Qiu M; Wang S; Pan C; Wang Y; Ou J
    Cell Physiol Biochem; 2018; 51(6):2872-2886. PubMed ID: 30562741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR‑494‑3p promotes the progression of endometrial cancer by regulating the PTEN/PI3K/AKT pathway.
    Zhu L; Wang X; Wang T; Zhu W; Zhou X
    Mol Med Rep; 2019 Jan; 19(1):581-588. PubMed ID: 30431102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CircVRK1 regulates tumor progression and radioresistance in esophageal squamous cell carcinoma by regulating miR-624-3p/PTEN/PI3K/AKT signaling pathway.
    He Y; Mingyan E; Wang C; Liu G; Shi M; Liu S
    Int J Biol Macromol; 2019 Mar; 125():116-123. PubMed ID: 30508543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long intergenic noncoding RNA 00641 inhibits breast cancer cell proliferation, migration, and invasion by sponging miR-194-5p.
    Mao Q; Lv M; Li L; Sun Y; Liu S; Shen Y; Liu Z; Luo S
    J Cell Physiol; 2020 Mar; 235(3):2668-2675. PubMed ID: 31490021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA SPRY4-IT1 sponges miR-101-3p to promote proliferation and metastasis of bladder cancer cells through up-regulating EZH2.
    Liu D; Li Y; Luo G; Xiao X; Tao D; Wu X; Wang M; Huang C; Wang L; Zeng F; Jiang G
    Cancer Lett; 2017 Mar; 388():281-291. PubMed ID: 27998761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. circSLC8A1 sponges miR-671 to regulate breast cancer tumorigenesis via PTEN/PI3k/Akt pathway.
    Zhu Q; Zhang X; Zai HY; Jiang W; Zhang KJ; He YQ; Hu Y
    Genomics; 2021 Jan; 113(1 Pt 1):398-410. PubMed ID: 33301895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
    Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
    Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long Noncoding RNA FAL1 Promotes Cell Proliferation, Invasion and Epithelial-Mesenchymal Transition Through the PTEN/AKT Signaling Axis in Non-Small Cell Lung Cancer.
    Pan C; Yao G; Liu B; Ma T; Xia Y; Wei K; Wang J; Xu J; Chen L; Chen Y
    Cell Physiol Biochem; 2017; 43(1):339-352. PubMed ID: 28854421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-101-3p inhibits the growth and metastasis of non-small cell lung cancer through blocking PI3K/AKT signal pathway by targeting MALAT-1.
    Zhang X; He X; Liu Y; Zhang H; Chen H; Guo S; Liang Y
    Biomed Pharmacother; 2017 Sep; 93():1065-1073. PubMed ID: 28738500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.